<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: E2F-1 expression is positively associated with <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumour growth</z:e> in oesophageal <z:hpo ids='HP_0002860'>squamous-cell carcinomas</z:hpo> (OSCC), while it exhibits oncosuppressive features in <z:mp ids='MP_0009314'>colonic adenocarcinomas</z:mp> (AC) </plain></SENT>
<SENT sid="1" pm="."><plain>To date there are no data regarding E2F-1 expression and its relationship with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> kinetics (proliferation, <z:mpath ids='MPATH_3'>apoptosis</z:mpath>) in <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> that develop on Barrett oesophagus </plain></SENT>
<SENT sid="2" pm="."><plain>AIM: As oesophageal <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> occur almost exclusively in the metaplastic <z:e sem="disease" ids="C1258085" disease_type="Disease or Syndrome" abbrv="">Barrett epithelium</z:e> and the opposing E2F-1 behaviour seems to be cell and tissue-type dependent, we examined the manner in which E2F-1 acts in ACs of Barrett oesophagus </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We estimated the immunohistochemical expression of E2F-1, Ki-67, caspase-3 and p53 immunohistochemical status in 35 Barrett oesophagus ACs </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: E2F-1 immunopositivity correlated inversely with Ki-67, by semi-serial section and statistical analysis (p = 0.023, Spearman correlation) </plain></SENT>
<SENT sid="5" pm="."><plain>Semi-serial section analysis revealed a direct association between E2F-1 and caspase-3 staining </plain></SENT>
<SENT sid="6" pm="."><plain>No correlation was found with p53 status </plain></SENT>
<SENT sid="7" pm="."><plain>Cases with higher E2F-1 immunoexpression exhibited longer survival (p = 0.047, Cox-regression) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: E2F-1 expression was negatively related to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> proliferation in ACs of Barrett oesophagus </plain></SENT>
<SENT sid="9" pm="."><plain>Additionally, E2F-1 immunohistochemical status correlated positively with patient survival </plain></SENT>
<SENT sid="10" pm="."><plain>These findings are opposite from those seen in OSCCs, suggesting that the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-suppressing E2F-1 behaviour in oesophageal <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> is possibly due to the intestinal-type nature of the metaplastic Barrett mucosa </plain></SENT>
</text></document>